BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29706380)

  • 1. Outcomes after autoBMT in cancer survivors.
    Gunjur A
    Lancet Oncol; 2018 Apr; ():. PubMed ID: 29706380
    [No Abstract]   [Full Text] [Related]  

  • 2. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.
    Schultz KA; Chen L; Chen Z; Kawashima T; Oeffinger KC; Woods WG; Nicholson HS; Neglia JP
    Pediatr Blood Cancer; 2014 Apr; 61(4):729-36. PubMed ID: 24285698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male sexual function after autologous blood or marrow transplantation.
    Schimmer AD; Ali V; Stewart AK; Imrie K; Keating A
    Biol Blood Marrow Transplant; 2001; 7(5):279-83. PubMed ID: 11400950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous graft-versus-host disease in a porcine bone marrow transplant model.
    Kunisaki SM; Haller GW; Shimizu A; Kitamura H; Colvin RB; Sachs DH
    Transplantation; 2002 Aug; 74(4):465-71. PubMed ID: 12352903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature.
    Potenza L; Luppi M; Riva G; Morselli M; Ferrari A; Imovilli A; Giacobbi F; Temperani P; Donelli A; Narni F; Torelli G
    Am J Hematol; 2006 Jan; 81(1):45-50. PubMed ID: 16369953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
    Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplant in acute myeloid leukemia in first remission.
    Cassileth PA; Andersen J; Lazarus HM; Colvin OM; Bennett JM; Stadtmauer EA; Kaizer H; Weiner RS; Edelstein M; Oken MM
    J Clin Oncol; 1993 Feb; 11(2):314-9. PubMed ID: 8426209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and risk behaviors in survivors of childhood acute myeloid leukemia: a report from the Children's Oncology Group.
    Schultz KA; Chen L; Chen Z; Zeltzer LK; Nicholson HS; Neglia JP
    Pediatr Blood Cancer; 2010 Jul; 55(1):157-64. PubMed ID: 20232426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of erythropoiesis after bone marrow transplantation: quantitative reticulocyte counting.
    Davies SV; Cavill I; Bentley N; Fegan CD; Poynton CH; Whittaker JA
    Br J Haematol; 1992 May; 81(1):12-7. PubMed ID: 1520610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants.
    Slavin S; Nagler A
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S59-67. PubMed ID: 9457396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous graft-versus-host disease.
    Karasuno T
    Int J Hematol; 1997 Feb; 65(2):105-13. PubMed ID: 9071814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of erythropoietic/hematopoietic reconstitution after BMT by highly fluorescent reticulocyte counts compares favorably with traditional peripheral blood cell counting.
    Kanold J; Bezou MJ; Coulet M; Quainon F; Malpuech G; Travade P; Deméocq F
    Bone Marrow Transplant; 1993 Apr; 11(4):313-8. PubMed ID: 7683553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
    Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
    Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia in a bone marrow transplantation unit.
    Akan H; Koç H; Arslan O; Beksaç M; Ilhan O; Gürman G; Ozcan M; Ustün C; Konuk N; Uysal A
    Int J Antimicrob Agents; 1997 Mar; 8(2):127-30. PubMed ID: 18611793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
    To LB; Roberts MM; Haylock DN; Dyson PG; Branford AL; Thorp D; Ho JQ; Dart GW; Horvath N; Davy ML
    Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.
    Fefer A; Robinson N; Benyunes MC; Bensinger WI; Press O; Thompson JA; Lindgren C
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S48-53. PubMed ID: 9457394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.